Inhalation Drug Delivery News

  1. HCmed, Formosa Laboratories, And Formosa Pharmaceuticals Signed MoU To Form A Global CDMO For Inhalation Treatment Drugs 3/6/2022

    HCmed Innovations, Co., Ltd. (HCmed) announced that it has formed a strategic alliance with Formosa Laboratories, Inc. (TPEx: 4746) and Formosa Pharmaceuticals, Inc. (TPEx: 6838) to expand its business in the inhalation treatment field, providing contract development and manufacturing services

  2. Kindeva Drug Delivery To Manufacture New, Greener Inhalers At UK Manufacturing Site To Help Cut Carbon Emissions 2/16/2022

    One of the UK’s biggest asthma inhaler manufacturers has today announced its intention to invest in its UK manufacturing site to support the development of a new generation of greener inhalers, designed to help support the National Health Service (NHS) to cut a contributor to its emissions.

  3. Nutriband Inc. And Kindeva Drug Delivery Sign Feasibility Agreement To Develop AVERSA™ Fentanyl, An Abuse Deterrent Fentanyl Patch 1/10/2022

    The feasibility agreement is focused on adapting Kindeva’s commercial transdermal manufacturing process to incorporate AVERSA technology.